<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03074721</url>
  </required_header>
  <id_info>
    <org_study_id>16-022</org_study_id>
    <nct_id>NCT03074721</nct_id>
  </id_info>
  <brief_title>PCI Suite: Road Map Fusion Imaging in Coronary Diagnostics and Therapy</brief_title>
  <acronym>PCI Suite</acronym>
  <official_title>PCI Suite: Road Map Fusion Imaging in Coronary Diagnostics and Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heinrich-Heine University, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Philips Medical Systems</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The PCI Suite is developed by Philips Medical Systems, a Philips Healthcare company. The
      proposed PCI Suite is a new software package which can be used during coronary interventions.
      The software package includes two sub-packages, known as StentBoost and Cardiac Roadmapping.

      The patient will undergo standard of care medical treatment for his or her cardiac condition.
      During the procedure, the physician may make angiograms for diagnosis and as reference for
      device navigation as part of the standard care. These angiograms will be automatically
      processed in PCI Suite and displayed on fluoroscopy for navigation support. In case a balloon
      catheter is inserted into the coronary arteries, the physician may take cine images as part
      of the standard care. These images can be automatically enhanced in PCI Suite. The primary
      objective of this prospective, mono-center, randomized clinical trial is to evaluate the
      amount of contrast medium used during percutaneous coronary intervention.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 24, 2017</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amount of contrast medium</measure>
    <time_frame>Baseline</time_frame>
    <description>Determination during PCI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiac and cerebrovascular events</measure>
    <time_frame>Baseline, after 6 months, after 12 months</time_frame>
    <description>Major adverse cardiac and cerebrovascular events (MACCE) are defined as occurence of myocardial ischemia, stroke, acute stent thrombosis, major bleeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural success</measure>
    <time_frame>Baseline</time_frame>
    <description>Defined by an open target vessel with a maximum of 20% residual stenosis and TIMI III flow</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure duration</measure>
    <time_frame>Baseline</time_frame>
    <description>Determination of duration of PCI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>area dosage product</measure>
    <time_frame>Baseline</time_frame>
    <description>Determination during PCI</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Coronary Disease</condition>
  <arm_group>
    <arm_group_label>PCI with PCI Suite Software</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional PCI</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PCI Suite Software</intervention_name>
    <description>PCI with PCI Suite Software</description>
    <arm_group_label>PCI with PCI Suite Software</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>conventional PCI</intervention_name>
    <description>conventional PCI without PCI Software</description>
    <arm_group_label>conventional PCI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  hemodynamically relevant type A or B lesion

        Exclusion Criteria:

          -  hemodynamically relevant type C lesion

          -  NSTEMI/STEMI

          -  declined to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tobias Zeus, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Cardiology, Pulmonology and Vascular Medicine, University Hospital Duesseldorf</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tobias Zeus, MD</last_name>
    <phone>+492118118800</phone>
    <email>pruefer.kardiologie@med.uni-duesseldorf.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rabea Wagstaff, M.A.</last_name>
    <phone>+492118118914</phone>
    <email>rabea.wagstaff@med.uni-duesseldorf.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Division of Cardiology, Pulmonary Disease and Vascular Medicine</name>
      <address>
        <city>Dusseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tobias Zeus, MD</last_name>
    </contact>
    <investigator>
      <last_name>Tobias Zeus, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christian Jung, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Florian BÃ¶nner, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laura Kleinebrecht, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2017</study_first_submitted>
  <study_first_submitted_qc>March 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2017</study_first_posted>
  <last_update_submitted>May 2, 2017</last_update_submitted>
  <last_update_submitted_qc>May 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

